Rapid Therapeutic Science Laboratories, Inc RTSL

RTSLOTC
RTSL
Rapid Therapeutic Science Laboratories, IncOTC
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Rapid Therapeutic Science Laboratories, Inc operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access to certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the State of Texas. The company was founded on February 22, 2013 and is headquartered in Dallas, TX.